Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis

Journal of Clinical Investigation

Volumn 109, Issue 2, 2002, Pages 233-241

  Howard, Laurence M ^a   Ostrovidov, Serge ^a   Smith, Cassandra E ^a   Dal Canto, Mauro C ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; INFLAMMATION; INTERFERON PRODUCTION; LYMPH NODE CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0036153434     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214374     Document Type: Article

References (48)

1. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse
2. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein
3. Epidemiologic evidence for multiple sclerosis as an infection
4. Multiple sclerosis: More genes versus environment
5. Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T cell-mediated autoimmune diseases
6. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
7. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
8. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
9. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
10. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
11. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction
12. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
13. The many roles of CD40 in cell-mediated inflammatory responses
14. Functional role of CD40 and its ligand
15. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
16. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ
17. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody
18. A central role of CD40 ligand in the regulation of CD4+ T-cell responses
19. CD40-CD40 ligand: A multifunctional receptor-ligand pair
20. Activation of human dendritic cells through CD40 cross-linking
21. CD40 and CD154 in cell-mediated immunity
22. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
23. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40
24. CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response
25. Primary demyelination in Theiler's virus infection. An ultrastructural study
26. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide
27. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation
28. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome
29. The CD40 antigen and its ligand
30. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice
31. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
32. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response
33. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
34. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice
35. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway
36. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
37. Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance
38. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
39. CD40-CD40L interactions in atherosclerosis
40. Role for CD40-CD40 ligand interactions in the immune response to solid tumours
41. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity
42. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity
43. The roles of CD28 and CD40 ligand in T cell activation and tolerance
44. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on alpha 1, 3-fucosyltransferase VII gene expression
45. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway
46. Expression of functional CD40 by vascular endothelial cells
47. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction
48. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated costimulation